Phase 3 study of quizartinib (AC220) monotherapy vs salvage chemotherapy (SC) in patients (pts) with FLT3-ITD+ acute myeloid leukemia (AML) refractory to or relapsed (R/R) after 1st-line treatment with or without hematopoietic stem cell transplant (HSCT) consolidation: the QuANTUM-R study

J. Cortes, G. Gammon, S. Khaled, G. Martinelli, A. Kramer, B. Steffen, D. Hogge, B. A. Jonas, H. Dombret, A. Perl

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)vi327
JournalAnnals of Oncology
StatePublished - Oct 1 2016
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this